Abstract
Studies by Amabile et al reported in this issue of Blood use a novel strategy of teratoma formation from human induced pluripotent stem cells (iPSCs) to isolate hematopoietic stem/progenitor cells (HSPCs) capable of in vivo engraftment and producing functional lymphocytes.1.
Original language | English (US) |
---|---|
Pages (from-to) | 1245-1246 |
Number of pages | 2 |
Journal | Blood |
Volume | 121 |
Issue number | 8 |
DOIs | |
State | Published - Feb 21 2013 |
Externally published | Yes |